Purchase Order 75H71224P00104
- Not listed
- This is a federal contract awarded by the Indian Health Service (IHS), a civilian agency, to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The contract is a delivery order worth $199,060.08 with a performance period from July 1, 2025 to June 30, 2026. It is a firm fixed-price contract with no set-aside designation. The contract requires Cepheid to provide GeneXpert diagnostic systems, molecular reagents, test kits, and associated...
- The U.S. Indian Health Service (IHS) awarded a $115,600.00 firm fixed-price purchase order contract to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, for the provision of CEPHEID TEST KITS. The contract has an ultimate completion date of July 10, 2025 and was awarded on January 30, 2024. Cepheid is a prime contractor that provides advanced diagnostic systems and test kits for infectious diseases, genetic conditions, and clinical testing to various federal agencies,...
- The Department of Health and Human Services Indian Health Service has awarded a $19,206.10 firm-fixed-price purchase order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. This contract does not have a set-aside designation. Cepheid will provide diagnostic testing equipment, reagents, consumables, and associated maintenance and support services to support the Indian Health Service's clinical testing programs. Cepheid is a leading provider of molecular diagnostics...
- This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Indian Health Service, a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $416,991.94, is for the supply of CEPHEID diagnostic products and has an ultimate completion date of July 30, 2025. The contract is a delivery order with a firm fixed-price pricing type and does not have a set-aside designation. Cepheid is the prime contractor...
- This is a firm fixed-price purchase order awarded by the Indian Health Service, a civilian federal agency, to Cepheid, a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The $59,235.71 contract is for the provision of Combined Cepheid Service, with an ultimate completion date of January 31, 2030. Cepheid is an experienced federal contractor, holding several significant Indefinite Delivery Vehicle (IDV) contracts with agencies such as the Department of...
- This is a firm fixed-price delivery order contract awarded by the Indian Health Service (IHS), a civilian agency, to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract is valued at $176,833.92 and covers the period from July 1, 2025, to June 30, 2026. Cepheid will provide the IHS with its GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services for detecting infectious diseases such as COVID-19, influenza, and...
- This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the U.S. Department of Health and Human Services' Indian Health Service (IHS) agency. The contract is a $5,000,000 single-award Indefinite Delivery Vehicle (IDV) running from June 17, 2025 to June 30, 2026, which will provide GeneXpert diagnostic systems and associated services. This contract is not designated as a set-aside. Cepheid has also been awarded other significant federal IDV...
- The Department of Health and Human Services Indian Health Service awarded a delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, on September 2, 2021. The contract, which does not have a set-aside designation, has a potential value of $170,000.00 and a completion date of July 27, 2022. Cepheid, a subsidiary of Danaher Corporation, provides a range of goods and services related to diagnostic testing equipment, reagents, and consumables, as well as...
- This is a firm fixed-price purchase order awarded by the Indian Health Service, a civilian agency, to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract is for the provision of 4 replacement CEPHEID units with a trade-in allowance, with a total ceiling value of $255,070.43 and a completion date of June 9, 2029. The contract does not have a set-aside designation. Cepheid is the prime contractor and has participated in other federal contract vehicles and...
- This is a firm fixed-price delivery order awarded by the Indian Health Service to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The $450,000.00 contract is for the provision of CEPHEID SUPPLIES, with a period of performance through June 30, 2025. Cepheid is a prime contractor and has previously been awarded Indefinite Delivery Vehicles (IDVs) with the Indian Health Service and Department of Veterans Affairs for molecular diagnostic products and services, including...
The U.S. Indian Health Service awarded a $168,475.00 firm fixed-price purchase order contract to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The contract is for the administrative modification to extend the period of performance to December 31, 2025. Cepheid provides comprehensive molecular diagnostic technologies to various federal agencies, including the Department of Veterans Affairs (VA), Indian Health Service (IHS), and Defense Logistics Agency (DLA), primarily through the development and supply of GeneXpert diagnostic systems, molecular reagents, test kits, and associated maintenance services. The contract does not have a set-aside designation. Cepheid holds several significant federal Indefinite Delivery Vehicle (IDV) contracts that enable continuous procurement of its molecular diagnostic solutions for federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($21k) | 8/6/25 | |
| Not listed | Not listed | $189.4k | 4/9/24 |